Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors.
Chan JA, Geyer S, Zemla T, Knopp MV, Behr S, Pulsipher S, Ou FS, Dueck AC, Acoba J, Shergill A, Wolin EM, Halfdanarson TR, Konda B, Trikalinos NA, Tawfik B, Raj N, Shaheen S, Vijayvergia N, Dasari A, Strosberg JR, Kohn EC, Kulke MH, O'Reilly EM, Meyerhardt JA.
Chan JA, et al. Among authors: kulke mh.
N Engl J Med. 2024 Sep 16. doi: 10.1056/NEJMoa2403991. Online ahead of print.
N Engl J Med. 2024.
PMID: 39282913